23 related articles for article (PubMed ID: 35451606)
1. Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies.
Hamm CA; Baumgärtner GL; Padhani AR; Froböse KP; Dräger F; Beetz NL; Savic LJ; Posch H; Lenk J; Schallenberg S; Maxeiner A; Cash H; Günzel K; Hamm B; Asbach P; Penzkofer T
Eur Radiol; 2024 Mar; ():. PubMed ID: 38538841
[TBL] [Abstract][Full Text] [Related]
2. Micro-ultrasound for the detection of clinically significant prostate cancer in biopsy-naive men with negative MRI.
Albers P; Bennett J; Evans M; Martin ES; Wang B; Broomfield S; Martín AM; Tu W; Fung C; Kinnaird A
Can Urol Assoc J; 2024 Apr; ():. PubMed ID: 38587980
[TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of transitional zone prostate cancer miss-detected by multiparametric magnetic resonance imaging.
Chen X; Li W; Yang J; Huang C; Zhou C; Chen Y; Lin Y; Hou J; Huang Y; Wei X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6943-6952. PubMed ID: 36847840
[TBL] [Abstract][Full Text] [Related]
4. Should PI-RADS 3 be Subclassified According to ADC Values in the Transition Zone?
Teica RV; Ciofiac CM; Florescu LM; Gheonea IA
Curr Health Sci J; 2023; 49(4):564-570. PubMed ID: 38559832
[TBL] [Abstract][Full Text] [Related]
5. Embedding new technology into clinical ultrasound practice: Is role extension for sonographers the key to improving patient pathways?
Parker P; Edwards H; Twiddy M; Whybrow P; Rigby A
Ultrasound; 2023 May; 31(2):84-90. PubMed ID: 37144232
[TBL] [Abstract][Full Text] [Related]
6. MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study.
Cornud F; Lefevre A; Flam T; Dumonceau O; Galiano M; Soyer P; Camparo P; Barral M
Eur Radiol; 2020 Sep; 30(9):4838-4846. PubMed ID: 32350662
[TBL] [Abstract][Full Text] [Related]
7. The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis.
Avolio PP; Lughezzani G; Paciotti M; Maffei D; Uleri A; Frego N; Hurle R; Lazzeri M; Saita A; Guazzoni G; Casale P; Buffi NM
Urol Oncol; 2021 Dec; 39(12):832.e1-832.e7. PubMed ID: 34183255
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
9. The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.
Martel P; Rakauskas A; Dagher J; La Rosa S; Meuwly JY; Roth B; Valerio M
Prog Urol; 2022 Jun; 32(6S1):6S26-6S32. PubMed ID: 36719643
[TBL] [Abstract][Full Text] [Related]
10. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
11. Post-MRI transrectal micro-ultrasonography of transition zone PI-RADS > 2 lesions for biopsy guidance.
Cornud F; Lefevre A; Camparo P; Barat M; Dumonceau O; Galiano M; Flam T; Soyer P; Barral M
Eur Radiol; 2022 Nov; 32(11):7504-7512. PubMed ID: 35451606
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Diagnosis with Micro-ultrasound: What We Know now and New Horizons.
Dias AB; Ghai S
Radiol Clin North Am; 2024 Jan; 62(1):189-197. PubMed ID: 37973243
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
